Where does Roche Diagnostics Operations, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Roche Diagnostics Operations, Inc. ranks #690 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Roche Diagnostics Operations, Inc. hold?

Roche Diagnostics Operations, Inc. holds 654 US utility patents granted between 2015 and 2025, spanning 111 technology areas.

What is Roche Diagnostics Operations, Inc.'s Innovation Score?

Roche Diagnostics Operations, Inc. has an Innovation Score of 62.0 out of 100 (top 3% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Roche Diagnostics Operations, Inc.'s patent grant rate increasing or decreasing?

Roche Diagnostics Operations, Inc.'s recent grant velocity is -15% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Roche Diagnostics Operations, Inc.'s patents?

Roche Diagnostics Operations, Inc.'s patents average 13.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Roche Diagnostics Operations, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Roche Diagnostics Operations, Inc.

Q: What technology areas does Roche Diagnostics Operations, Inc. focus on?

Roche Diagnostics Operations, Inc.'s top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 482 patents, ranking #14 of 7,863 assignees active in that subclass. Grants appear in 111 CPC subclasses total.

USPTO PatentsView assignee record - 654 granted patents across 111 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Roche ranks #690 of 49,997 tracked US assignees by granted-patent volume, with 654 patents across 111 technology areas.

#690
of 49,997 US assignees by volume: Top 3%
by Innovation Score (62.0/100): 13.5
avg claims per patent: -15%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R690 · US Corporation #690 · 654 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MID 654 grants
TOP-DECILE #690/49,997
PHOTO-FINISH pSemi
CPC-WIDE G01N · 111 areas
INNOV-STRONG 62.0/100
CLAIMS-RICH 13.5 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -15% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: pSemi Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Roche’s 62.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 22.4 pts (36%) Velocity 6.6 pts (11%) Breadth 25.0 pts (40%) Claim depth 8.1 pts (13%)

Qualcomm Incorporated · highest

85
Global Graphene Group · near

62
NGK Insulators · near

62
WM Intellectual… · near

62
Roche Diagnostics… · this assignee

62
Ramot at Tel-Aviv… · near

62
3D Lighting… · lowest

7

What this shows Roche's Innovation Score is 62.0/100 (top 3% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Roche?

Each dot is one of Roche’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Roche’s own 13.5 claims/patent is at or below the 18.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Roche vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

How Roche's grant cadence moved

Between 2020–2024, Roche Diagnostics Operations, Inc. received 280 grants versus 331 in 2015–2019 (-15% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2015 at 101 grants and bottomed in 2020 at 39. Lead class G01N accounts for 73.7% of the portfolio across 111 subclasses. Volume neighbours: Inventec Corporation (#685) and Incyte Corporation (#693).

Roche's three-year grant acceleration

From 2019–2021 to 2022–2024, Roche Diagnostics Operations, Inc. moved from 179 to 176 grants (0.98x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,226. See the growth leaderboard.

Inventec

656
Immersion

656
American Express…

655
TS Tech

655
psemi

654
Roche Diagnostics… ◀

654
Nederlandse Organ…

653
Hughes Network Sy…

652
Incyte

652

What this shows Roche holds 654 patents at rank #689, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Roche

By rank, the assignees closest to #689 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Roche's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Roche, neither rank-band nor same-CPC leaders (those blocks stay above). In G01N (Investigating OR Analysing Materials BY Determining Their…), Roche ranks #14 of 7,863 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (62 here).

Ramot at Tel-Aviv University Ltd. 62 NGK Insulators, Ltd. 62 Global Graphene Group, Inc. 62 WM Intellectual Property Holdings, L.L.C. 62

Similar claim depth

Nearest assignees by average claims per patent (13.5 here).

GE Lighting Solutions LLC 13.5 avg Paramount BED Co., Ltd. 13.5 avg Delaware Capital Formation, Inc. 13.5 avg PlayNitride Display Co., Ltd. 13.5 avg

Roche's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

62 Top 3% higher than 97% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Roche Diagnostics Operations, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	101	15.4%
2016	48	7.3%
2017	49	7.5%
2018	58	8.9%
2019	75	11.5%
2020	39	6.0%
2021	65	9.9%
2022	55	8.4%
2023	50	7.6%
2024	71	10.9%
2025partial year	43	6.6%

Which technologies does Roche Diagnostics Operations, Inc. patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 482

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 141

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 78

B65G - Transport OR Storage Devices, e.g. Conveyors FOR Loading OR Tipping, Shop Conveyor Systems OR Pneumatic Tube Conveyors 73

A61B - DIAGNOSIS; SURGERY; Identification 58

Y10T - Technical Subjects Covered BY Former US Classification 57

C07K - Peptides 49

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 37

G06F - Electric Digital Data Processing 34

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 32

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 22

C12Y - Enzymes 21

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 20

C07D - Heterocyclic Compounds 16

H01J - Electric Discharge Tubes OR Discharge Lamps 15

Top 15 of 111 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Roche Diagnostics Operations, Inc.'s patent record in context - here's where to go next.

Roche Diagnostics Operations, Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 73.7% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #690 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Roche Diagnostics Operations, Inc. against Inventec Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 62.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.